Rejoni, Inc., a commercial-stage women's health company focused on uterine health, today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA P250051) for the ...
Angelo Hooker, MD, PhD, focuses here on intrauterine adhesions, discussing clinical challenges, management strategies, and ...
Rejoni, Inc., a privately held clinical-stage company, today announced the completion of enrollment of 150 patients in the Juveena Hydrogel pivotal clinical study. This announcement marks a ...
Womed Leaf® Resorbable Adhesion Barrier receives PMA approval for women suffering from moderate to severe intrauterine adhesions, a major cause for female infertility MONTPELLIER, France, September 16 ...
To investigate the effect of pelvic adhesions on reproductive outcomes following high-intensity focused ultrasound (HIFU) ablation in patients with adenomyosis. A total of 396 patients with ...
Intrauterine adhesions are fibrotic sequelae of endometrial injury that compromise female fertility and reproductive health globally. Surgical separation remains the standard management but is often ...
Chinese researchers have demonstrated new reconstructable uterus-derived materials (RUMs) that allow almost complete recovery from severe uterine injury. Relevant results were published online in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results